FDA Sets Date For Resubmitted Dupixent in Inflammatory Skin Disease
The FDA has accepted the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric...
The FDA has accepted the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric...
New Delhi: Lung cancer is one of the most common and lethal cancers globally, with about 2.2 million new cases...
» Go to news main Respiratory Therapy grad makes impact in field, cultivates her joy in healthcare during undergraduate education...
Key factsRegular physical activity provides significant physical and mental health benefits.In adults, physical activity contributes to prevention and management of...
The National University Health System (NUHS) and Sahlgrenska University Hospital have partnered with AstraZeneca, Ericsson, and Business Sweden to...
Snow on ground reflecting sun Sunburns and skin cancer don’t have an exclusive partnership with hot...
Pulmonx (Nasdaq: LUNG), a leader in minimally invasive treatments for severe lung disease, has announced...
There has been a number of healthtech initiatives in Singapore this year. What makes an initiative not only tick the...
A 25-year-old woman with vitiligo universalis, a severe form of vitiligo that causes nearly complete loss of skin color across...